CWGCX
Price
$68.12
Change
+$0.24 (+0.35%)
Updated
Jun 6 closing price
Net Assets
130.86B
MWEMX
Price
$48.10
Change
+$0.33 (+0.69%)
Updated
Jun 6 closing price
Net Assets
2.19B
Interact to see
Advertisement

CWGCX vs MWEMX

Header iconCWGCX vs MWEMX Comparison
Open Charts CWGCX vs MWEMXBanner chart's image
American Funds Capital World Gr&Inc C
Price$68.12
Change+$0.24 (+0.35%)
VolumeN/A
Net Assets130.86B
MFS Global Equity R6
Price$48.10
Change+$0.33 (+0.69%)
VolumeN/A
Net Assets2.19B
CWGCX vs MWEMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. MWEMX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Buy and MWEMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 131B vs. MWEMX (2.19B). MWEMX pays higher dividends than CWGCX: MWEMX (1.04) vs CWGCX (0.87). CWGCX was incepted earlier than MWEMX: CWGCX (24 years) vs MWEMX (13 years). CWGCX (1.49) is less costly to investors than MWEMX (0.84). CWGCX is a more actively managed with annual turnover of: 27.00 vs. MWEMX (8.00). MWEMX has a lower initial minimum investment than CWGCX: MWEMX (0) vs CWGCX (250). CWGCX annual gain was more profitable for investors over the last year : 5.53 vs. MWEMX (-4.57). CWGCX return over 5 years is better than : 42.30 vs. MWEMX (5.52).
CWGCXMWEMXCWGCX / MWEMX
Total Expense Ratio1.490.81184%
Annual Report Gross Expense Ratio1.490.84177%
Fund Existence24 years13 years-
Gain YTD8.7116.368137%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets131B2.19B5,982%
Annual Yield % from dividends0.871.0483%
Returns for 1 year5.53-4.57-121%
Returns for 3 years26.86-6.44-417%
Returns for 5 years42.305.52767%
Returns for 10 years49.3135.62138%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV6.200.47
+8.12%
Verve Therapeutics
PIII6.620.14
+2.24%
P3 Health Partners Inc
VSAT9.210.09
+0.99%
ViaSat
NLY19.060.18
+0.95%
Annaly Capital Management
RELI1.47-0.04
-2.65%
Reliance Global Group Inc.